Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) : a randomised, controlled, open-label, phase 3 trial

Paz-Ares Luis and Dvorkin Mikhail and Chen Yuanbin and Reinmuth Niels and Hotta Katsuyuki and Trukhin Dmytro and Statsenko Galina and Hochmair Maximilian J and Özgüroğlu Mustafa and Ji Jun Ho and Voitko Oleksandr and Poltoratskiy Artem and Ponce Santiago and Verderame Francesco and Havel Libor and Bondarenko Igor and Kazarnowicz Andrzej and Losonczy György and Conev Nikolay V and Armstrong Jon and Byrne Natalie and Shire Norah and Jiang Haiyi and Goldman Jonathan W and Kollaborációs szervezet: CASPIAN investigators and Somfay Attila and et al. (kollab. közrem.): Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) : a randomised, controlled, open-label, phase 3 trial.
LANCET, 394 (10212). pp. 1929-1939. ISSN 0140-6736 (2019)

[thumbnail of 1-s2.0-S0140673619322226-main.pdf] Text
1-s2.0-S0140673619322226-main.pdf - Published Version
Closed access: Repository staff only

Download (462kB) | Request a copy
Item Type: Journal Article
Szerzők száma: 222
Journal or Publication Title: LANCET
Date: 2019
Volume: 394
Number: 10212
Page Range: pp. 1929-1939
ISSN: 0140-6736
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 31168342
DOI azonosító: https://doi.org/10.1016/S0140-6736(19)32222-6
Date Deposited: 2024. Mar. 27. 12:48
Last Modified: 2024. Mar. 27. 12:48
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/29981
Web of Science® Times Cited: 1161 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year